RXL:NYE-ProShares Ultra Health Care (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 113.3305

Change

-0.90 (-0.79)%

Market Cap

N/A

Volume

595.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-20 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

-1.57 (-4.47%)

USD 11.53B
QLD ProShares Ultra QQQ

-0.45 (-0.46%)

USD 6.60B
FNGU MicroSectors FANG+ Index 3X Le..

-4.33 (-1.03%)

USD 5.13B
SSO ProShares Ultra S&P500

-0.40 (-0.45%)

USD 4.93B
UPRO ProShares UltraPro S&P500

-0.57 (-0.67%)

USD 3.53B
TECL Direxion Daily Technology Bull..

-0.87 (-1.03%)

USD 3.15B
USD ProShares Ultra Semiconductors

-2.40 (-2.10%)

USD 1.02B
LABU Direxion Daily S&P Biotech Bul..

-3.72 (-2.58%)

USD 0.94B
DPST Direxion Daily Regional Banks ..

-6.65 (-5.98%)

USD 0.77B
YINN Direxion Daily FTSE China Bull..

-0.01 (-0.04%)

USD 0.76B

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

-1.13 (0%)

USD 0.10B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

-0.73 (0%)

USD 9.12B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

N/A

N/A
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 0.24B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

-0.77 (0%)

USD 0.17B
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 23.99% 60% D- 86% B+
Dividend Return 0.57% 31% F 11% F
Total Return 24.56% 61% D- 84% B
Trailing 12 Months  
Capital Gain 33.85% 32% F 82% B
Dividend Return 0.81% 24% F 10% F
Total Return 34.66% 32% F 80% B-
Trailing 5 Years  
Capital Gain 119.51% 80% B- 89% A-
Dividend Return 2.33% 40% F 7% C-
Total Return 121.84% 80% B- 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 15.44% 42% F 79% B-
Dividend Return 15.66% 39% F 76% C+
Total Return 0.22% 21% F 5% F
Risk Return Profile  
Volatility (Standard Deviation) 27.10% 96% N/A 38% F
Risk Adjusted Return 57.76% 93% A 76% C+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.